Cadila Healthcare
Quarterly Results Analysis [Jun2022]
Cadila Healthcare Quarterly Results
Consolidated | Jun2022 UnAudited |
Mar2022 Audited |
Dec2021 UnAudited |
Sep2021 UnAudited |
Jun2021 UnAudited |
Mar2021 Audited |
Dec2020 UnAudited |
Sep2020 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹4,073 Cr | ₹3,864 Cr | ₹3,655 Cr | ₹3,785 Cr | ₹4,002 Cr | ₹3,670 Cr | ₹3,633 Cr | ₹3,659 Cr |
Expenses | ₹3,240 Cr | ₹3,146 Cr | ₹2,903 Cr | ₹2,924 Cr | ₹3,030 Cr | ₹2,821 Cr | ₹2,867 Cr | ₹2,845 Cr |
Operating Income | ₹833 Cr | ₹718 Cr | ₹753 Cr | ₹861 Cr | ₹972 Cr | ₹850 Cr | ₹767 Cr | ₹814 Cr |
Other Income | ₹66 Cr | ₹79 Cr | ₹61 Cr | ₹53 Cr | ₹32 Cr | ₹-30 Cr | ₹27 Cr | ₹28 Cr |
Interest | ₹34 Cr | ₹39 Cr | ₹31 Cr | ₹30 Cr | ₹27 Cr | ₹23 Cr | ₹27 Cr | ₹45 Cr |
Depreciation | ₹181 Cr | ₹185 Cr | ₹183 Cr | ₹185 Cr | ₹173 Cr | ₹175 Cr | ₹176 Cr | ₹175 Cr |
Profit Before Tax | ₹681 Cr | ₹573 Cr | ₹599 Cr | ₹604 Cr | ₹803 Cr | ₹548 Cr | ₹590 Cr | ₹490 Cr |
Profit After Tax | ₹563 Cr | ₹464 Cr | ₹488 Cr | ₹504 Cr | ₹646 Cr | ₹754 Cr | ₹486 Cr | ₹390 Cr |
EPS | ₹5.06 | ₹3.88 | ₹4.89 | ₹29.32 | ₹5.73 | ₹6.63 | ₹5.15 | ₹4.62 |
Industry Peers & Returns | 1W | 1M | 1Y |
Cadila Healthcare | 8.3% | 5.1% | -33.9% |
SUN PHARMACEUTICAL INDUSTRIES | -0.2% | 6.2% | 16% |
DIVIS LABORATORIES | -4.7% | -1.3% | -19.7% |
DR REDDYS LABORATORIES | 2.6% | -5.4% | -11% |
CIPLA | -0.7% | 7.8% | 13.8% |
GLAND PHARMA | 4.5% | -3.4% | -44.2% |
PIRAMAL ENTERPRISES | 11.2% | 13.1% | -31.4% |
TORRENT PHARMACEUTICALS | -1.1% | 3.5% | 1.4% |
ALKEM LABORATORIES | -4.9% | -5.7% | -16.6% |
Cadila Healthcare Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 5.41 % |
Y-o-Y | 1.77 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Jun2022 | ₹4,073 Cr | 5.41 | |
Mar2022 | ₹3,864 Cr | 5.71 | |
Dec2021 | ₹3,655 Cr | -3.43 | |
Sep2021 | ₹3,785 Cr | -5.42 | |
Jun2021 | ₹4,002 Cr | 9.03 | |
Mar2021 | ₹3,670 Cr | 1.03 | |
Dec2020 | ₹3,633 Cr | -0.71 | |
Sep2020 | ₹3,659 Cr | - |
Cadila Healthcare Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 16.07 % |
Y-o-Y | -14.29 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Jun2022 | ₹833 Cr | 16.07 | |
Mar2022 | ₹718 Cr | -4.62 | |
Dec2021 | ₹753 Cr | -12.58 | |
Sep2021 | ₹861 Cr | -11.43 | |
Jun2021 | ₹972 Cr | 14.41 | |
Mar2021 | ₹850 Cr | 10.83 | |
Dec2020 | ₹767 Cr | -5.81 | |
Sep2020 | ₹814 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 10.12 % |
Y-o-Y | -15.81 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Jun2022 | 20.45% | 10.12 | |
Mar2022 | 18.57% | -9.81 | |
Dec2021 | 20.59% | -9.45 | |
Sep2021 | 22.74% | -6.38 | |
Jun2021 | 24.29% | 4.92 | |
Mar2021 | 23.15% | 9.72 | |
Dec2020 | 21.1% | -5.13 | |
Sep2020 | 22.24% | - |
Cadila Healthcare Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 21.33 % |
Y-o-Y | -12.84 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Jun2022 | ₹563 Cr | 21.33 | |
Mar2022 | ₹464 Cr | -5.04 | |
Dec2021 | ₹488 Cr | -3.02 | |
Sep2021 | ₹504 Cr | -22.00 | |
Jun2021 | ₹646 Cr | -14.33 | |
Mar2021 | ₹754 Cr | 55.07 | |
Dec2020 | ₹486 Cr | 24.75 | |
Sep2020 | ₹390 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 15.08 % |
Y-o-Y | -14.38 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Jun2022 | 13.81 % | 15.08 | |
Mar2022 | 12 % | -10.18 | |
Dec2021 | 13.36 % | 0.45 | |
Sep2021 | 13.3 % | -17.54 | |
Jun2021 | 16.13 % | -21.43 | |
Mar2021 | 20.53 % | 53.55 | |
Dec2020 | 13.37 % | 25.54 | |
Sep2020 | 10.65 % | - |
Cadila Healthcare Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 30.41 % |
Y-o-Y | -11.69 % |
Quarters | EPS | % Change | |
---|---|---|---|
Jun2022 | ₹5.06 | 30.41 | |
Mar2022 | ₹3.88 | -20.65 | |
Dec2021 | ₹4.89 | -83.32 | |
Sep2021 | ₹29.32 | 411.69 | |
Jun2021 | ₹5.73 | -13.57 | |
Mar2021 | ₹6.63 | 28.74 | |
Dec2020 | ₹5.15 | 11.47 | |
Sep2020 | ₹4.62 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
